October 23, 2024 – Therapy with DNA repair inhibitors in early phase clinical trials

The results from BiTEs have been somewhat limited by (i) poor delivery kinetics and penetration into tumours, and (ii) on-target off-tumour activity, leading to dose-limiting toxicities [65]

October 23, 2024 climat2050

The results from BiTEs have been somewhat limited by (i) poor delivery kinetics and penetration into tumours, and (ii) on-target off-tumour activity, leading to dose-limiting

Day: October 23, 2024

﻿The results from BiTEs have been somewhat limited by (i) poor delivery kinetics and penetration into tumours, and (ii) on-target off-tumour activity, leading to dose-limiting toxicities [65]

The results from BiTEs have been somewhat limited by (i) poor delivery kinetics and penetration into tumours, and (ii) on-target off-tumour activity, leading to dose-limiting toxicities [65]